Serge Saxonov - 22 May 2025 Form 4 Insider Report for 10x Genomics, Inc. (TXG)

Role
Chief Executive Officer, Director
Signature
/s/ Eric S. Whitaker, as Attorney-in-Fact for Serge Saxonov
Issuer symbol
TXG
Transactions as of
22 May 2025
Net transactions value
-$77,540
Form type
4
Filing time
27 May 2025, 17:08:05 UTC
Previous filing
19 Mar 2025
Next filing
02 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Saxonov Serge Chief Executive Officer, Director 10X GENOMICS, INC., 6230 STONERIDGE MALL ROAD, PLEASANTON /s/ Eric S. Whitaker, as Attorney-in-Fact for Serge Saxonov 27 May 2025 0001786720

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TXG Class A Common Stock Sale $77,540 -9,343 -0.85% $8.30 1,083,625 22 May 2025 Direct F1
holding TXG Class A Common Stock 27 22 May 2025 See footnote F2
holding TXG Class A Common Stock 870 22 May 2025 See footnote F3
holding TXG Class A Common Stock 213,250 22 May 2025 See footnote F4
holding TXG Class A Common Stock 22,570 22 May 2025 See footnote F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
F2 The shares are held by the Andromeda Trust, for which the Reporting Person serves as trustee.
F3 The shares are held by the Sirius Trust, for which the Reporting Person serves as trustee.
F4 The shares are held by the Y/S Descendants' Trust, for which the Reporting Person serves as trustee.
F5 The shares are held by the Y/S Pot Trust, for which the Reporting Person serves as trustee.